156925-22-3 Usage
Description
((R)-morpholin-2-yl)methanol, also known as (R)-2-hydroxymethylmorpholine, is a chiral chemical compound with the molecular formula C5H11NO2. It is a colorless, water-soluble liquid that serves as a versatile reagent in organic synthesis. As a chiral compound, it possesses specific stereochemical properties due to its (R)-enantiomer configuration. Its molecular structure allows for various chemical transformations, making it an important intermediate in the synthesis of a wide range of compounds, including pharmaceuticals, agrochemicals, and other fine chemicals.
Uses
Used in Pharmaceutical Industry:
((R)-morpholin-2-yl)methanol is used as a building block for the synthesis of various pharmaceutical compounds. Its unique stereochemistry and reactivity enable the development of innovative drugs with improved efficacy and selectivity.
Used in Agrochemical Industry:
((R)-morpholin-2-yl)methanol is utilized as a key intermediate in the production of agrochemicals, such as pesticides and herbicides. Its ability to undergo various chemical transformations allows for the creation of effective and targeted agrochemicals.
Used in Fine Chemicals Industry:
((R)-morpholin-2-yl)methanol is employed as a versatile intermediate in the synthesis of fine chemicals, including specialty chemicals, fragrances, and flavorings. Its molecular structure and reactivity contribute to the development of high-quality and diverse chemical products.
Used in Organic Synthesis:
((R)-morpholin-2-yl)methanol is used as a reagent in organic synthesis, facilitating various chemical reactions and transformations. Its unique properties make it a valuable component in the synthesis of complex organic molecules and compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 156925-22-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,9,2 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 156925-22:
(8*1)+(7*5)+(6*6)+(5*9)+(4*2)+(3*5)+(2*2)+(1*2)=153
153 % 10 = 3
So 156925-22-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO2/c7-4-5-3-6-1-2-8-5/h5-7H,1-4H2/t5-/m1/s1
156925-22-3Relevant articles and documents
MORPHOLINO COMPOUNDS, USES AND METHODS
-
Paragraph 0172-0175; 0181; 0182, (2014/06/11)
The invention relates to morpholino-derivatives according to Formula (I) or stereoisomers or pharmaceutically acceptable salts or solvate thereof, wherein R1, R2, R3, R4, R5, R6, R7/s
PROCESS FOR PRODUCING 2-HYDROXYMETHYLMORPHOLINE SALT
-
Page/Page column 13-14, (2011/12/03)
The present invention relates to a production method of a 2-hydroxymethylmorpholine salt, which includes crystallization from a solution containing 2-hydroxymethylmorpholine represented by the following formula (1) 1,4-oxazepane compound represented by th
PYRAZIN-2-YL-PYRIDIN-2-YL-AMINE AND PYRAZIN-2-YL-PYRIMIDIN-4-YL-AMINE COMPOUNDS AND THEIR USE
-
, (2009/05/29)
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain biarylamine compounds (referred to herein as BAA compounds), and especially certain pyrazin- 2 - yl -pyridin- 2 -yl -amine and pyrazine - 2 - yl -pyrimidin- 4 - yl -amine compounds of formula (I), which, inter alia, inhibit Checkpoint Kinase 1 (CHK1 ) kinase function The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit CHK1 kinase function, and in the treatment of diseases and conditions that are mediated by CHK1. that are ameliorated by the inhibition of CHK1 kinase function, etc., including proliferative conditions such as cancer, etc., optionally in combination with another agent, for example, (a) a DNA topoisomerase I or Il inhibitor; (b) a DNA damaging agent; (c) an antimetabolite or TS inhibitor; (d) a microtubule targeted agent; and (e) ionisiπq radiation. wherein: -X= is independently -CRA5= or -N=; and the rest of the substituents are as specified in the claims.